Grants per year
Grants
Search results
-
Finished
-
Cystic Fibrosis Lung Transplant Transition - Regional Dissemination Network
Dartmouth College, Cystic Fibrosis Foundation
1/1/19 → 5/31/20
Project: Research project
-
-
Multicenter study of patient-reported gastrointestinal symptoms in people with Cystic Fibrosis (GALAXY)
Seattle Children's, Cystic Fibrosis Foundation
12/1/18 → 11/30/19
Project: Research project
-
Sexual and Reproductive Health in Adult Women with Cystic Fibrosis
University of Pittsburgh, Cystic Fibrosis Foundation
10/1/18 → 9/30/20
Project: Research project
-
Prot #VX17-445-102: A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/M
Greenphire, Inc., Vertex Pharmaceuticals Incorporated
6/5/18 → 6/5/21
Project: Research project
-
Optimization of Nasal Airway Cell Usage for CF Drug Discovery
Rosalind Franklin University of Medicine and Science, Cystic Fibrosis Foundation
1/15/18 → 1/14/19
Project: Research project
-
Prot #PTI-801-01: A Multi-Center, Randomized, Placebo-Controlled, Phase 1, Two-Part Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, an
Rho, Inc., Proteostasis Therapeutics, Inc.
9/26/17 → 9/26/20
Project: Research project
-
Prot #VX16-445-001: A Phase 1/2 Study of VX-445 in Healthy Subjects and Subjects with Cystic Fibrosis
Covance Inc., Vertex Pharmaceuticals Incorporated
7/3/17 → 7/3/20
Project: Research project
-
Implementation of Outpatient Clinical Pharmacy Services: Award for a Pharmicst
11/1/16 → 10/31/19
Project: Research project
-
-
Fellowship in support of Marc Sala: Program for Adult Care Excellence (PACE) Program
7/1/16 → 6/30/19
Project: Research project
-
Developing Innovative Gastroenterology Specialty Training (DIGEST) Program
6/1/16 → 5/31/19
Project: Research project
-
PRC Vice Chair
Cystic Fibrosis Foundation Therapeutics, Inc.
5/1/16 → 12/31/18
Project: Research project
-
Prot #VX15-371-101: A Phase 2a, Randomized, Double-blind, Placebo-controlled, Incomplete Block, Crossover Study to Evaluate the Safety and Efficacy of VX-371 in Subjects Aged 12 Years or Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Covance Inc., Vertex Pharmaceuticals Incorporated
4/14/16 → 4/14/19
Project: Research project
-
TEACH Trial: Testing the Effect of Adding Chronic Azithromycin to Inhaled Tobramycin. A randomized, placebo-controlled, double-blinded trial of azithromycin 500 mg thrice weekly in combination with inhaled tobramycin
Seattle Children's, Cystic Fibrosis Foundation Therapeutics, Inc.
1/1/16 → 11/30/20
Project: Research project
-
Fixed Price Subproject for "TEACH Trial: Testing the Effect of Adding Chronic Azithromycin to Inhaled Tobramycin. A randomized, placebo-controlled, double-blinded trial of azithromycin 500 mg thrice weekly in combination with inhaled tobramycin"
Seattle Children's, Cystic Fibrosis Foundation Therapeutics, Inc.
1/1/16 → 11/30/20
Project: Research project
-
Implementation of the Depression and Anxiety Guidelines: Award for A Mental Health Coordinator
1/1/16 → 12/31/19
Project: Research project
-
Prot #VX14-661-108: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous f
Quintiles, Inc., Vertex Pharmaceuticals Incorporated
12/4/15 → 12/4/18
Project: Research project
-
Phase 2 Study of Intravenous Gallium Nitrate in the Treatment of Cystic Fibrosis
University of Washington, Food and Drug Administration
7/1/15 → 6/30/18
Project: Research project